Chick-fil-A has partnered with Faction, a California-based company that develops autonomous fleets. Photo courtesy of Faction

This article was written by CultureMap Columnist Ken Hoffman and originally appeared on CultureMap's Hoffman's Houston editorial series.

Next time you order “curbside delivery” from the Chick-fil-A on Kirby Drive and the Southwest Freeway, one of the top performing Chick-fil-A’s in the country, don’t be surprised if your Spicy Chicken Sandwich and waffle fries are delivered by a driverless three-wheeled electric vehicle that looks like a cross between a Big Wheels kiddie car and the Mars Rover.

It’s a first in Houston. Chick-fil-A has partnered with Faction, a California-based company that develops autonomous (driverless) fleets. Earlier this week I met with Ain McKendrick, the founder and CEO of Faction, who explained how Chick-fil-A’s futuristic curbside delivery system works.

The key word is curbside. Unlike popular food deliverers like DoorDash and UberEats, Faction’s robotic vehicles don’t involve a human driver who will bring the food to your door, with the expectation of receiving a tip.

When a Faction vehicle delivers your food, you will get a text that the vehicle has arrived, and you’ll walk to the curb and pick up your food from the car that’s parked in front of your house. Throw some clothes on, please. The neighbors may see you.

When you order from the Kirby/Southwest Chick-fil-A on the Chick-fil-A app, and click on delivery, you’ll be given a choice of how you want your food brought to your house. You can still request DoorDash or another service. If you choose “curbside delivery,” watch for a Faction vehicle pulling up in front of your house. You’ll pop open the storage door, open the separate boxes that keep your sandwiches and fries toasty and your soft drinks cold, and run back into your house to dig in.

Right now, the Kirby/Southwest Freeway Chick-fil-A is using two Faction vehicles to supplement the regular delivery cars during crush time. Faction promises (they couch the claim by saying “estimates”) you’ll get your food within 30 minutes. Currently human “supervisors” are doing ride-alongs while the vehicles are mapping out the restaurant’s four-mile delivery area. Faction follows its vehicles’ progress on a video board at home base making sure each delivery goes right.

The electric vehicles are licensed and insured and can do 75 miles-per-hour on highways. But because of Houston’s notorious traffic, Faction has programmed the vehicles to stay on surface streets and below the speed limit. That’s how I get around, too. I got tired of that inexplicable traffic jam on the Southwest Freeway when it bends toward downtown.

McKendrick said the driverless vehicles will have memorized Houston streets well enough by August to operate without human supervisors.

Will customers be OK with their Chick-fil-A food delivered by driverless vehicles? So far it’s not a problem. In fact, McKendrick said some customers wait outside with their phone cameras ready so they can share photos of the delivery. Sharing their waffle fries is a different story.

I’m a skeptic when it comes to electric and driverless vehicles. I asked McKendrick …

What happens if a dog runs in front of a Faction vehicle? He said it will automatically stop for the pooch.

What if there’s a children’s birthday party on my block and there’s no parking space in front of my house? He said the vehicle will pull to the side and flash warning lights until the customer picks up their food.

So what’s in it for Chick-fil-A to partner with Faction? Kirby/Southwest Freeway Chick-fil-A owner Jesse Chaluh said it’s a more efficient way of offering delivery service to his customers. He thinks that his restaurant eventually will require five or more Faction vehicles to handle the demand.

While each vehicle currently delivers one order to one customer per run, eventually the technology will improve where each vehicle will be able to make several deliveries with each foray onto the streets of Houston.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

7+ can't-miss Houston business and innovation events in June 2026

where to be

Editor's note: The FIFA World Cup comes to Houston this month, joined by major energy conferences and a lineup of fan-favorite, recurring events. Here’s what not to miss and how to register. Please note: this article may be updated to add more events.


June 1-4 — CLEANPOWER 2026 Conference and Exhibition

CLEANPOWER unites policymakers, experts, and corporate leaders to solve the challenges that none can solve alone. This must-attend, four-day conference is packed with cutting-edge discussions about wind, solar, storage, and transmission; dealmaking; networking; and fun.

This event begins June 1 at the George R. Brown Convention Center. Register here.

June 2 — Humans of Healthcare

Houston Methodist Center for Innovation will present its quarterly speaker series, Humans of Healthcare. The series will feature a panel of experts who will share about their career paths and discuss the nuances of the health care industry. This month's session will focus on today’s nursing landscape, the industry’s expectations of nurses and what career paths are possible in the field.

The event is Tuesday, June 2, from 5-6:30 p.m. at the Ion. Register here.

June 9 — Greentown Go Make Kickoff

Head to the Ion to celebrate the Greentown Go Make 2026 cohort. The open-innovation program with Shell Catalysts & Technologies and Technip Energies focuses on catalytic solutions for industrial decarbonization and the energy transition. Hear pitches from the founders and network with a select group of startups while enjoying food and drink.

This event is Tuesday, June 9, from 5:30-8 p.m. Register here.

June 9-10 — Texas Brain Economy Summit

The Center for Houston’s Future and UTMB are bringing the Texas Brain Economy Summit back to Houston this summer to continue to position the region as a global leader in brain health. Expect to hear from eaders of global institutions, including the World Economic Forum, U.S. Chamber of Commerce, McKinsey Health Institute, Global Brain Economy Initiative, Davos Alzheimer’s Collaborative, Business Collaborative for Brain Health (UsAgainstAlzheimer’s), Rice University, Memorial Hermann, MD Anderson and many others. Read InnovationMap's full preview of the event here.

This event begins Tuesday, June 9. Purchase tickets here.

June 10 — MIT Future of Healthcare Technology Forum

The MIT Club of South Texas will host an in-person forum to explore how innovation, government and policy are changing the healthcare industry. The event will feature MIT alumni and Houston healthcare leaders, including Dr. Tim Boone, dean of the Texas A&M School of Engineering Medicine; Cynthia Reinhart-King, chair of bioengineering at Rice University; Dr. Tony Lin, CEO and chairman emeritus of Kelsey-Seybold Clinic; and others.

This event is Wednesday, June 10, from 5:15-8:30 p.m. at the TAMU EnMed Building. Register here.

June 11 — Goals & Gigawatts: Houston Energy & Climate Week The Power of & Kickoff Party

Come watch the Mexico City FIFA opening match while celebrating energy and innovation at the Goals & Gigawatts Kickoff Party. The event will feature food, drinks, and a showcase on Houston Energy & Climate Week. Learn what to expect and how to get involved in the HECW before closing the night with a DJ and karaoke.

This event is Thursday, June 11, from 1:30-6:30 p.m. Find more information here.

June 16-17 — Energy Projects Conference & Expo

The Energy Projects Conference & Expo (EPC Show) is the largest event in North America for professionals working at the heart of major energy projects. The essential event for engineering, construction, commissioning, operations and maintenance across multiple energy sectors brings together five leading conferences under one roof. Conference subjects span LNG exporting, hydrogen and ammonia, midstream, petrochem and refining, and sustainable aviation fuels.

This event begins June 16 at George R. Brown Convention Center. Register here.

June 25 – NASA Tech Talk

Every fourth Thursday of the month, NASA experts, including longtime engineer Montgomery Goforth, present on technology development challenges NASA’s Johnson Space Center and the larger aerospace community are facing, and how they can be leveraged by Houston’s innovation community. Stick around after for drinks and networking at Second Draught.

This event is Thursday, June 25, from 6-7 p.m. at the Ion. Register here.

Houston researchers report promising first in-human trial for implantable cancer therapy

cancer breakthrough

When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

“Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

“This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”